Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study*
暂无分享,去创建一个
K. White | F. Palella | Y. Lie | D. Porter | J. Toma | S. Chuck | M. Miller | Yuping Tan | R. Kulkarni | K. Andreatta | Owen D Solberg | Suqin Cai | Michael D. Miller